BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li L, Yu J, Cheng S, Peng Z, Ben-David Y, Luo H. Transcription factor Fli-1 as a new target for antitumor drug development. Int J Biol Macromol 2022;209:1155-68. [PMID: 35447268 DOI: 10.1016/j.ijbiomac.2022.04.076] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang T, Chen D, Ye W, Chen W, Zhang M, Hao J, Xu L, Bai X, Mao S. Effect and mechanism of apelin on lipopolysaccharide induced acute pulmonary vascular endothelial barrier dysfunction. Sci Rep 2023;13:1560. [PMID: 36707689 DOI: 10.1038/s41598-023-27889-6] [Reference Citation Analysis]
2 Mikhailova EV, Romanova IV, Bagrov AY, Agalakova NI. Fli1 and Tissue Fibrosis in Various Diseases. Int J Mol Sci 2023;24. [PMID: 36768203 DOI: 10.3390/ijms24031881] [Reference Citation Analysis]
3 Mo M, Ma Y, Yu J, Ahmad M, Wan X, Yu Z, Xu B, Luo H. A Novel Chalcone Derivative Regulates the Expression and Phosphorylation of ERK1/2 by Inhibiting Fli-1 Promoter Activity for Preventing the Malignant Progression of Erythroleukemia. Catalysts 2022;13:84. [DOI: 10.3390/catal13010084] [Reference Citation Analysis]
4 Li L, Yang M, Yu J, Cheng S, Ahmad M, Wu C, Wan X, Xu B, Ben-David Y, Luo H. A Novel L-Phenylalanine Dipeptide Inhibits the Growth and Metastasis of Prostate Cancer Cells via Targeting DUSP1 and TNFSF9. Int J Mol Sci 2022;23:10916. [PMID: 36142828 DOI: 10.3390/ijms231810916] [Reference Citation Analysis]